Clinical Acumen Versus Androgen Receptor Variant 7 Circulating Tumor Cells in Decision-Making for Men with Advanced Prostate Cancer
- PMID: 31615710
- DOI: 10.1016/j.eururo.2019.09.028
Clinical Acumen Versus Androgen Receptor Variant 7 Circulating Tumor Cells in Decision-Making for Men with Advanced Prostate Cancer
Comment on
-
Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer.Eur Urol. 2020 Feb;77(2):170-177. doi: 10.1016/j.eururo.2019.08.020. Epub 2019 Oct 21. Eur Urol. 2020. PMID: 31648903 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical